Hereditary tumors of the gastrointestinal tract (FAP/HNPCC);Hereditare tumoren des gastrointestinaltrakts (FAP/HNPCC)

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 15, Issue 2, 1999, Pages 163-172

  Gebert, J ^a   Von Knebel Doeberitz, C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

DNA mismatch repair Molecular diagnostic; Familial adenomatous polyposis; Hereditary non polyposis colorectal cancer; Microsatellite instability

Indexed keywords

TUMOR PROTEIN;

ADENOMATOUS POLYP; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; COLORECTAL CANCER; DNA REPAIR; DNA SEQUENCE; GENE MUTATION; GERM LINE; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; PROCTOCOLECTOMY; REVIEW;

EID: 0032804495     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012549     Document Type: Review

References (21)

1. Church TR, Ederer F, Mandel JS: Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-1448.
2. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
3. Bapat B, Noorani H, Cohen Z, Berk T, Mitri A, Gallie B, Pritzker K, Gallinger S, Detsky AS: Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 1999;44:698-703.
4. Petersen GM: Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med 1994;26:205-208.
5. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, Slominski Castor S, Cayouette MC, Priluck I, Luce MC: Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995;76:2427-2433.
6. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E: Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Am J Gastroenterol 1996;91:2489-2493.
7. Polakis P: The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1997;1332:F127-147.
8. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
9. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
10. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JK, Paraskeva C, Petersen GM, Hamilton SR, Vogelstein B, Kinzler KW: The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993;90:2846-2850.
11. Friedl W, Meuschel S, Caspari R, Lamberti C, Krieger S, Sengteller M, Propping P: Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the A PC gene. A clue for understanding the function of the APC protein. Hum Genet 1996;97:579-584.
12. Dihlmann S, Gebert J, Siermann A, Herfarth C, von Knebel Doeberitz M: The APC-gene mutation in codon 1309 can activate β-catenin-mediated transcription by a dominant negative effect of mutant APC-genes - molecular basis for genotype-phenotype correlations in familial adenomatous polyposis patients. Cancer Res (in press).
13. von Knebel DoeberitzM, Gebert J, Herfarth C: Effect of molecular diagnostic procedures on surgical therapy of malignant diseases. Chirurg 1996;67:967-979.
14. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329: 1982-1987.
15. Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, Schouten WR, Oostvogel HJ, Kuijpers JH, Tops CM, Meera Khan P: Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-435.
16. Wu JS, Paul P, McGannon EA, Church JM: APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998;227:57-62.
17. Bachmann KD, Bartram CR, Chang-Claude J, Fonatsch C, Propping P: Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dtsch Ärzteblatt 1998;95:A1396-1403.
18. Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78:1149-1167.
19. Kullmann F, Bocker T, Schölmerich J, Rüschoff J: Mikrosatelliteninstabilität - ein neuer Aspekt in der Genetik und Molekularbiologie von hereditären nicht-polypösen und sporadischen kolorektalen Tumoren. Z Gastroenterol 1996;34:813-822.
20. Peltomaki P, Vasen HF: Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-1158.
21. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110.